Single jab will offer ‘protective bubble' to premature babies this winter
From late September, the health service will offer nirsevimab to protect babies born before 32 weeks against respiratory syncytial virus (RSV).
The jab, which offers six months protection in a single dose, will replace monthly injections of palivizumab previously offered.
RSV is a common cause of coughs and colds and usually gets better by itself, but can cause severe illness for babies and older adults.
It is estimated that about 30,000 youngsters are admitted to hospital with the virus every year in the UK, with about 30 babies dying.
According to NHS England, data shows premature babies are three times more likely to go to hospital with RSV and are 10 times more likely to need intensive care when compared to full-term babies.
Health systems in Scotland, Wales and Northern Ireland will also offer nirsevimab from autumn, meaning about 9,000 babies in the UK are set to benefit.
Dr Claire Fuller, co-national medical director for NHS England said: 'This injection will provide premature babies with a protective bubble against RSV just in time for the colder months.
'It will offer a long-lasting defence helping to avoid unnecessary hospitalisations and serious illness – giving babies the best possible start in life and shielding them from harm.'
Since September 2024, pregnant women have been eligible for an RSV jab from 28 weeks onwards to boost their immune system and pass antibodies to their unborn babies to protect them in the first weeks of life.
However, this new drug works differently to the jab, as premature babies born before 32 weeks have limited or no protection given from the vaccinations recommended for pregnant women.
Dr Conall Watson, consultant epidemiologist at the UK Health Security Agency, said: 'Having an RSV vaccine from week 28 in every pregnancy is key to protecting your baby against RSV bronchiolitis. Most RSV hospital admissions in babies can be prevented by vaccination.
'This new NHS nirsevimab immunisation programme will offer really important protection for very premature babies born before they can be protected by mum's antenatal vaccination.'
John Stewart, director of specialised commissioning at NHS England said: 'For babies born very prematurely, the risk of contracting RSV in their first winter is high and extremely serious.
'This new medication will provide vulnerable infants with their own suit of armour that protects against what can be a life-threatening infection.'
Public health minister Ashley Dalton said: 'By rolling out nirsevimab this September, we're ensuring that our most at-risk infants, including those who are born too early to benefit from maternal vaccination, are protected in the best possible way.'
Trial data shows nirsevimab offers more than 80% protection against RSV compared to about 55% with palivizumab, NHS England said.
Nirsevimab will also be offered on a seasonal basis to babies and young children with weakened immune systems or complex heart and lung conditions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
2 hours ago
- Times
Weight-loss jabs linked to five deaths in Scotland
Weight-loss injections have been linked to the deaths of five people in Scotland, while hundreds more report having become ill after using them. The jabs were developed to suppress appetite among obese patients with type 2 diabetes but have become more commonly used as a quick-fix diet aid. Last year a Scottish nurse, Susan McGowan, was the first person in the UK whose death was directly linked to the prescription-only medication. Now, however, the Medicines and Healthcare Regulatory Agency (MHRA) has said it has received five reports of fatalities linked to weight-loss jabs north of the border. The watchdog said in March that it had been notified 361 times since January last year of patients in Scotland who have suffered illness after taking the drugs.
Metro
5 hours ago
- Metro
Almost half of people don't wash their hands after using hospital toilets
It's one of the simplest steps in stopping germs from spreading – but nearly half of hospital toilet users are failing to wash their hands, a new study has found. Researchers at the University of Surrey put sensors on toilet and sink pipes to monitor hygiene behaviours at a hospital in Denmark. Over the roughly five-month period, they found that 43.7% of users did not wash their hands after using the loo. The figure, which jumped to 61.8% on some of the weeks, has raised the alarm about hygiene practices that some might have assumed had become commonplace after the pandemic. Dr Pablo Pereira Doel from the University of Surrey said people failing to wash their hands could 'directly affect patient safety' in hospitals. People were especially bad at washing their hands at the start and end of the day, as well as during mealtimes. NHS guidance says hand washing is 'one of the easiest ways to protect yourself and others from illnesses'. The advice hit the headlines at the start of the pandemic when then-Prime Minister Boris Johnson urged the nation to 'wash your hands for 20 seconds or more'. Professor Benjamin Gardner, from the University of Surrey, said: 'Strategies that raise awareness at the crucial point in a bathroom visit and easily understood messaging about how to wash effectively – like singing Happy Birthday twice over – can help people form handwashing habits that last.' The study took place at Bispebjerg hospital in Copenhagen, recording 2,636 over the course of 19 weeks. More Trending Professor Carrie Newlands, also of the University of Surrey, added the latest findings are 'not surprising'. 'Even simple behaviours like handwashing can lapse without reinforcement. 'In hospitals, lapses like these can have serious consequences – for patients and for the wider healthcare system. 'It's time we moved beyond posters and hand gel stations to more effective behavioural strategies.' Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: 21 seconds to go: The golden rule for how long it should take you to pee MORE: The reason why this famous TV doctor travelled 360 miles for surgery MORE: I'm a millennial – please stop sending me perimenopause memes
The Guardian
5 hours ago
- The Guardian
Measles surge shows why vaccinations are crucial
The increase in measles cases among young people in the UK, which has already led to one death in Liverpool, is worrying and tragic (Parents urged to get children vaccinated after measles death in Liverpool, 13 July). Vaccines alone don't save lives, vaccination does. And although we have safe and effective vaccines available in the UK, uptake is too low to unlock the large societal benefits that vaccination can bring. Immunisation uptake across adult, adolescent and childhood vaccines has decreased in the UK and internationally for almost every vaccine (UK worst in G7 for MMR jab rates, as 30m children worldwide not fully immunised, 15 July). This should raise major alarms for global health. There is misinformation and vaccine hesitancy, and we face a lack of knowledge regarding the importance of vaccines. We also need to deliver vaccines beyond standard healthcare settings. The UK's school-based human papillomavirus (HPV) vaccine programme for adolescents has been successful in increasing uptake, and similar programmes for childhood and adult vaccines in equivalent settings could be trialled. The government's 10‑year NHS plan proposes a new health visitor model to encourage vaccinations in communities. This is a commendable step towards increasing vaccination uptake. It could also help address broader issues around misinformation, hesitancy and inequalities in uptake. This, along with taking a long-term view to prevention, are critical components of revitalising uptake and protecting public BrasselSenior principal economist, Office of Health Economics It is heartbreaking that some children are seriously sick and a child has died from measles. Vaccines are the most successful and effective public health measures against infectious diseases. Measles is a highly contagious acute viral respiratory infection that is a primary cause of morbidity and mortality among infants and children under five, especially those with a compromised immune system or malnourished. Measles can lead to serious complications such as pneumonia, encephalitis, dehydration, ear infections, diarrhoea and irreversible vision loss. More than 90% of susceptible individuals around an infected person can catch the virus. Vaccine hesitancy is one of the top 10 global health threats, on par with climate change, HIV/Aids and lethal pathogens. It's time to raise awareness about the importance of vaccinations in combating infectious diseases, saving lives and protecting children, families and Munjed Farid Al QutobWillesden Green, London Melanie Pilcher of the Early Years Alliance says of children in nurseries who are not vaccinated against measles: 'It wouldn't be right to turn children away because it is a parental choice at the end of the day, and we have to respect that' (Nurseries in England bring in Covid-style protocols as measles cases rise, 19 July). No, you do not have to respect that choice because it is a shortsighted, dangerous and potentially deadly choice. Dangerous to the parents' own child and to the children around that child. In response, public health authorities must step up neighbourhood vaccination clinics, bringing the vaccine to families rather than demanding that families come to clinics. Matthew K BelmonteSheffield Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.
